Mood stabilization in the treatment of bipolar disorder: Focus on quetiapine

Human Psychopharmacology

Volumn 20, Issue 4, 2005, Pages 225-236

  Vieta, Eduard ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bipolar disorder; Mood stabilizers; Quetiapine

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE; GLUCOSE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; PROLACTIN; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AKATHISIA; ASTHENIA; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BODY WEIGHT DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE COURSE; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; DRUG UTILIZATION; DRUG WITHDRAWAL; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; INCREASED APPETITE; LITHIUM BLOOD LEVEL; MEDICAL LITERATURE; META ANALYSIS; MONOTHERAPY; NAUSEA; NEUROLOGIC DISEASE; OBESITY; ORTHOSTATIC HYPOTENSION; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RAPID CYCLING BIPOLAR DISORDER; RECURRENT DISEASE; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; XEROSTOMIA;

AFFECT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DIBENZOTHIAZEPINES; HUMANS; LONG-TERM CARE;

EID: 21044444737     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.689     Document Type: Review

References (86)

1. American Psychiatric Association. 2002. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159: 1-50.
2. Angst F, Stassen HH, Clayton PJ, Angst J. 2002. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 68: 167-181.
3. Arvanitis LA, Miller BG. 1997. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 42: 233-246.
4. Baldassano CF, Paulsson B, Brecher M. 2004. Quetiapine in the treatment of depressive symptoms in bipolar mania. Presented at the 157th Annual Meeting of the American Psychiatric Association, New York, NY, May 1-6.
5. Baldessarini RJ, Tohen M, Tondo L. 2000. Maintenance treatment in bipolar disorder. Arch Gen Psychiatry 57: 490-492.
6. Baldessarini RJ, Tondo L, Hennen J. 1999. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 60(Suppl. 2): 77-84.
7. Bowden C. 1997. Treatment of bipolar disorder. Curr Rev Mood Anxiety Disord 1: 167-176.
8. Bowden CL. 2001. Clinical correlates of therapeutic response in bipolar disorder. J Affect Disord 67: 257-265.
9. Bowden CL, Brugger AM, Swann AC, et al. 1994. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271: 918-924.
10. Bowden CL, Calabrese JR, McElroy SL, et al. 2000. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57: 481-489.
11. Bowden CL, Calabrese JR, Sachs G, et al. 2003. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60: 392-400.
12. Bowden CL, Asnis GM, Ginsberg LD, et al. 2004. Safety and tolerability of lamotrigine for bipolar disorder. Drug Saf 27: 173-184.
13. Bowden CL, Grunze H, Mullen J, et al. 2005. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry 66: 111-121.
14. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. 2002. Quetiapine in patients with bipolar disorder and cocaine dependence. Bipolar Disord 4: 406-411.
15. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. 1999. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60: 79-88.
16. Calabrese JR, Keck PE Jr, Macfadden W, et al. 2005. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry in press.
17. Calabrese JR, Shelton MD, Rapport DJ, Kujawa M, Kimmel SE, Caban S. 2001. Current research on rapid cycling bipolar disorder and its treatment. J Affect Disord 67: 241-255.
18. Calabrese JR, Vieta E, Shelton MD. 2003. Latest maintenance data on lamotrigine in bipolar disorder. Eur Neuropsychopharmacol 13(Suppl. 2): 57-66.
19. Calabrese JR, Woyshville MJ, Kimmel SE, Rapport DJ. 1993. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 13: 280-283.
20. Colom F, Vieta E. 2004. A perspective on the use of psychoeducation, cognitive-behavioral and interpersonal therapy for bipolar patients. Bipolar Disord 6: 1-7.
21. Dardennes R, Even C, Bange F, Heim A. 1995. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders: a meta-analysis. Br J Psychiatry 166: 378-381.
22. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. 2002. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 41: 1216-1223.
23. Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Leverich GS, Post RM. 1997. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. J Clin Psychiatry 58: 470-478.
24. Dunner DL, Fieve RR. 1974. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30: 229-233.
25. Emsley RA, Raniwalla J, Bailey PJ, Jones AM. 2000. A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol 15: 121-131.
26. Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. 1992. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 149: 108-111.
27. Frye MA, Ketter TA, Altshuler LL, et al. 1998. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 48: 91-104.
28. Garver DL. 2000. Review of quetiapine side effects. J Clin Psychiatry 61(Suppl. 8): 31-33.
29. Ghaemi SN. 2000. New treatments for bipolar disorder: the role of atypical neuroleptic agents. J Clin Psychiatry 61(Suppl. 14): 33-42.
30. Ghaemi S, Goldberg J, Ko J, McNally E. 2002. Quetiapine treatment of rapid-cycling bipolar disorder: an open prospective study. Int J Neuropsychopharmacol 5(Suppl. 1): S110.
31. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. 2003. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 290: 1467-1473.
32. Goodwin GM. 2003. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17: 149-173; discussion 147.
33. Grof P. 2003. 'Mood-stabilizers: the archeology of the concept' - by M Harris, S Chandran, N Chakraborty and D Healy: a commentary. Bipolar Disord 5: 453-455.
34. Grunze H, Kasper S, Goodwin G, et al. 2002. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Bipolar Disorder, Part I: Treatment of Bipolar Depression. World J Biol Psychiatry 3: 115-124.
35. Grunze H, Kasper S, Goodwin G, et al. 2003. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania. World J Biol Psychiatry 4: 5-13.
36. Gyulai L, Bowden CL, McElroy SL, et al. 2003. Maintenance efficacy of divalproex in the prevention of bipolar depression. Neuropsychopharmacology 28: 1374-1382.
37. Harris M, Chandran S, Chakraborty N, Healy D. 2003. Mood-stabilizers: the archeology of the concept. Bipolar Disord 5: 446-452.
38. Hennen J, Perlis RH, Sachs G, Tohen M, Baldessarini RJ. 2004. Weight gain during treatment of bipolar I patients with olanzapine. J Clin Psychiatry 65: 1679-1687.
39. Hirschfeld RM, Calabrese JR, Weissman MM, et al. 2003. Screening for bipolar disorder in the community. J Clin Psychiatry 64: 53-59.
40. Kasper S. 2003. Treatment of depressive symptoms with quetiapine. Expert Rev Neurotherapeutics 3: 89-95.
41. Keck PE Jr, Marcus R, Tourkodimitris S, et al. 2003a. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 160: 1651-1658.
42. Keck PE Jr, Versiani M, Potkin S, West SA, Giller E, Ice K. 2003b. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 160: 741-748.
43. Keck PE Jr, McElroy SL. 1996. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 16: 15S-23S.
44. Keck PE Jr, McElroy SL. 2003. Redefining mood stabilization. J Affect Disord 73: 163-169.
45. Keck PE Jr, McElroy SL, Richt N, Totten M. 2002. What makes a drug a primary mood stabilizer? Mol Psychiatry 7(Suppl. 1): S8-S14.
46. Keck PE Jr, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. 2004. The Expert Consensus Guideline Series. Treatment of bipolar disorder. Postgrad Med Special Report December: 1-120.
47. Ketter TA, Calabrese JR. 2002. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63: 146-151.
48. Khanna S, Vieta E, Lyons B, Grossman F, Kramer M. 2003. Risperidone monotherapy in acute bipolar mania (abstract P108). Bipolar Disord 5(Suppl. 1): 60.
49. Licht RW, Vestergaard P, Rasmussen NA, Jepsen K, Brodersen A, Hansen PE. 2001. A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatr Scand 104: 387-390.
50. Macfadden W, Calabrese JR, McCoy R, Minkwitz M, Wilson E, Mullen J. 2004. Anti-anxiety effects analysis of quetiapine in bipolar depression. Int J Neuropsychopharmacol 7(Suppl. 2): S157, abstract P01.189.
51. Macritchie KA, Hunt NJ. 2000. Does 'rebound mania' occur after stopping carbamazepine? A pilot study. J Psychopharmacol 14: 266-268.
52. Macritchie KAN, Geddes JR, Scott J, Haslam DRS, Goodwin GM. 2001. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder (Cochrane Review). Cochrane Database Syst Rev 3: CD003196.
53. McElroy SL, Keck PE Jr. 2000. Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 48: 539-557.
54. McIntyre R, Brecher M, Paulsson B, Huizar K, Mullen J. 2005. Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomized, parallel group, placebo-controlled trial. Eur Neuropsychopharmacol; in press.
55. Mullen J, Jibson MD, Sweitzer D. 2001. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther 23: 1839-1854.
56. Novartis Pharmaceuticals Corporation. 2002. Tegretol® (carbamazepine USP) prescribing information.
57. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. 1991. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 48: 62-68.
58. Post RM, Leverich GS, Altshuler LL, et al. 2003. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord 5: 310-319.
59. Prien RF, Rush AJ. 1996. National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder. Biol Psychiatry 40: 215-220.
60. Sachs GS. 1996. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 16: 32S-47S.
61. Sachs G, Chengappa KNR, Suppes T, et al. 2004. Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study. Bipolar Disord 6: 213-223.
62. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. 2002. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 159: 1146-1154.
63. Sajatovic M, Brescan DW, Perez DE, et al. 2001. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry 62: 728-732.
64. Sajatovic M, Mullen JA, Sweitzer DE. 2002. Efficacy of quetiapine and risperidone against depressive symptoms in outpatients with psychosis. J Clin Psychiatry 63: 1156-1163.
65. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. 1997. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 54: 549-557.
66. Swann AC, Bowden CL, Morris D, et al. 1997. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54: 37-42.
67. Tohen M, Chengappa KN, Suppes T, et al. 2002. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59: 62-69.
68. Tohen M, Chengappa KN, Suppes T, et al. 2004. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabilizer v. mood stabilizer alone. Br J Psychiatry 184: 337-345.
69. Tohen M, Hennen J, Zarate CM Jr, et al. 2000a. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 157: 220-228.
70. Tohen M, Jacobs TG, Grundy SL, et al. 2000b. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57: 841-849.
71. Tohen M, Ketter TA, Zarate CA, et al. 2003b. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 160: 1263-1271.
72. Tohen M, Sanger TM, McElroy SL, et al. 1999. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 156: 702-709.
73. Tohen M, Vieta E, Calabrese J, et al. 2003a. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 60: 1079-1088.
74. Tondo L, Baldessarini RJ, Floris G. 2001. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 178(Suppl. 41): S184-S190.
75. Vieta E. 2002. Do we need placebo control in maintenance studies in bipolar disorders? Bipolar Disord 4(Suppl. 1): 61.
76. Vieta E, Calabrese JR, Macfadden W, Minkwitz M, Mullen J. 2004. Quetiapine for the treatment of rapid-cycling bipolar depression. Acta Psychiatr Scand 110(s423): 41, abstract P90.
77. Vieta E, Parramon G, Padrell E, et al. 2002. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 4: 335-340.
78. Vieta E, Mullen J, Brecher M, Paulsson B, Jones M. 2005. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomized, placebo-controlled studies. Curr Med Res Opin; in press.
79. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. 2000. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157: 179-184.
80. Walden J, Schaerer L, Schloesser S, Grunze H. 2000. An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization. Bipolar Disord 2: 336-339.
81. Weisler RH, Kalali AH, Ketter TA, SPD417 Study Group. 2004. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. J Clin Psychiatry 65: 478-484.
82. Wieck A, Haddad P. 2002. Hyperprolactinaemia caused by antipsychotic drugs: this common side effect needs more attention. Br Med J 324: 250-252.
83. Yatham LN, Grossman F, Augustyns I, Vieta E, Ravindran A. 2003. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 182: 141-147.
84. Yatham LN, Paulsson B, Mullen J, Vagero AM. 2004. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J Clin Psychopharmacol 24: 599-606.
85. Zarate CA Jr. 2000. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry 61(Suppl. 8): 52-61.
86. Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J. 2000. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 61: 185-189.